News

‘Game-changing’ Alzheimer’s drug could STOP disease in its tracks – as the ‘most powerful weapon’ against condition yet
A NEW “game-changing” drug could stop the progression of Alzheimer’s disease, early trials suggest. Scientists say the ...
MedPage Today on MSN3d
Novel Anti-Amyloid Drug Aims to Outperform Current Standards
TORONTO -- An investigational antibody drug, designed to cross the blood-brain barrier (BBB) to eliminate amyloid-beta ...
New drug could halt Alzheimer’s
Trontinemab is one of a class of new medicines aimed at clearing amyloid plaques. The new findings from phase two trials ...
The Pharma Letter3d
Roche sets sights on Phase III with promising trontinemab data
Swiss pharma major Roche (ROG: SIX) has outlined ambitious plans to accelerate the development of trontinemab, its ...
BioSpace3d
Roche’s Next-Gen Alzheimer’s Antibody Clears or Reduces Amyloid Plaques in Seven Months
In a Phase Ib/IIa trial, 91% of patients receiving the highest dose of trontinemab were amyloid negative after seven months ...
New drug shows ‘game-changing’ potential to halt Alzheimer’s progression
A new Alzheimer’s drug has been hailed as a major breakthrough after clinical trials showed it could clear the harmful brain ...
GlobalData on MSN3d
Roche’s Alzheimer’s therapy shows continued benefit
Roche’s Alzheimer’s disease therapy has continued to show benefit for patients after 28 weeks in a long-term extension study.
Genentech and Roche Present New Insights in Alzheimer’s Disease Research Across Its Diagnostics and Pharmaceutical Portfolios at AAIC
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that new data from its Alzheimer’s ...
New drug, new hope: Roche tests Trontinemab potential to delay or prevent Alzheimer’s
Swiss drugmaker Roche Holding plans to investigate whether an experimental medicine can delay or prevent Alzheimer’s disease ...
‘Game-changing’ new Alzheimer’s drug could slow progression of disease
There are currently estimated to be 982,000 people with some form of dementia, including Alzheimer's in the UK ...
Stocktwits on MSN3d
Roche Bets Big On Alzheimer’s Prevention With New Trial As Duchenne Drug Setback Looms
Roche Holdings AG said it will begin a late-stage trial to evaluate whether its experimental Alzheimer’s drug, trontinemab, ...
Independent.ie on MSN1d
‘Game-changing’ new drug could slow progression of Alzheimer’s disease, research shows
An Alzheimer’s drug that clears away plaque build-up in the brain could slow progression of the disease and delay the onset of symptoms, early trials have shown. There is currently no cure for the ...